ReviewJournal of veterinary science2025
Genetic resistance to vector-borne hemoprotozoa in livestock: molecular markers, host-parasite interactions, and implications for breeding and control.
Review in Journal of veterinary science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Drug resistance in protozoan blood parasites of livestock across the Middle East and North Africa.Journal of veterinary science · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
importanceVector-borne hemoparasitic diseases, such as OBSERVATIONS: Resistance to hemoparasitic infections in livestock is strongly influenced by the genetic factors of the host. The key host genes involved in immune responses (e.g., BoLA-DRB3 and TLR4), oxidative stress defense (SOD2 and GPX1), drug metabolism (ABCB1 and CYP3A4), and ectoparasite resistance (MC1R and MHC) have been identified as contributors to resistance phenotypes. On the parasite side, the genes responsible for immune evasion (VSG and AP2), drug resistance (MDR1 and CYTB), and host cell invasion (AMA1 and HSP90) play pivotal roles in infection persistence and treatment failure. The advances in genomic and transcriptomic tools, including genome-wide association studies, CRISPR, and multi-omics profiling, have enhanced the understanding of these host-parasite interactions and enabled identification of the molecular markers for resistance traits. CONCLUSIONS AND RELEVANCE: Advanced genetic resistance offers a sustainable, long-term solution to managing vector-borne parasitic infections in livestock. The integration of resistance-associated markers into selective breeding programs, coupled with genome editing and real-time surveillance, can improve livestock resilience. Aligning these efforts with One Health strategies and collaborative genomic initiatives will be essential for achieving effective, regionally adapted disease control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.